The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Because BMI is highly correlated with insulin sensitivity [64], the apparent effect of BMI on the HbA1c-lowering efficacy observed in our study may be mediated by differences in insulin sensitivity among different ethnic groups.”
BackgroundBiology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 5×
“To date, two incretin hormones have been identified: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) [12, 13].”
BackgroundInfluentialDiabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Epidemic obesity and type 2 diabetes in Asia
Yoon, K.-H., Lee, J.-H., Kim, J.-W., Cho, J. H., Choi, Y.-H., Ko, S.-H., Zimmet, P., & Son, H.-Y. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69703-1 · Cited by 1,580
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2012) · Diabetes Care · doi:10.2337/dc12-s064 · Cited by 1,491
Aschner, P., Kipnes, M. S., Lunceford, J. K., Sanchez, M., Mickel, C., Williams-Herman, D. E., & for the Sitagliptin Study 021 Group (2006) · Diabetes Care · doi:10.2337/dc06-0703 · Cited by 880
NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874
Charbonnel, B., Karasik, A., Liu, J., Wu, M., Meininger, G., & for the Sitagliptin Study 020 Group (2006) · Diabetes Care · doi:10.2337/dc06-0706 · Cited by 790
Ramachandran, A., Wan Ma, R. C., & Snehalatha, C. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60937-5 · Cited by 782
Raz, I., Hanefeld, M., Xu, L., Caria, C., Williams-Herman, D., Khatami, H., & Sitagliptin Study 023 Group (2006) · Diabetologia · doi:10.1007/s00125-006-0416-z · Cited by 614
Lear, S. A., Humphries, K. H., Kohli, S., Chockalingam, A., Frohlich, J. J., & Birmingham, C. L. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.353 · Cited by 595
Hermansen, K., Kipnes, M., Luo, E., Fanurik, D., Khatami, H., Stein, P., & Sitagliptin Study 035 Group (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00744.x · Cited by 525
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review
Deacon, C. F. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01306.x · Cited by 525
Rosenstock, J., Brazg, R., Andryuk, P. J., Lu, K., & Stein, P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.007 · Cited by 514
Goldstein, B. J., Feinglos, M. N., Lunceford, J. K., Johnson, J., Williams-Herman, D. E., & for the Sitagliptin 036 Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0627 · Cited by 509
Ahrén, B., Gomis, R., Standl, E., Mills, D., & Schweizer, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2874 · Cited by 487
Bosi, E., Camisasca, R. P., Collober, C., Rochotte, E., & Garber, A. J. (2007) · Diabetes Care · doi:10.2337/dc06-1732 · Cited by 447
Kennedy, L. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79145-5 · Cited by 427
DeFronzo, R. A., Hissa, M. N., Garber, A. J., Luiz Gross, J., Yuyan Duan, R., Ravichandran, S., Chen, R. S., & for the Saxagliptin 014 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1984 · Cited by 416
Age- and Sex-Specific Prevalence of Diabetes and Impaired Glucose Regulation in 11 Asian Cohorts
the DECODA Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1770 · Cited by 396
DeFronzo, R. A., Okerson, T., Viswanathan, P., Guan, X., Holcombe, J. H., & MacConell, L. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802418851 · Cited by 373
Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
Fonseca, V., Schweizer, A., Albrecht, D., Baron, M. A., Chang, I., & Dejager, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0633-0 · Cited by 369
Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M. R., Tuomi, T., & Groop, L. C. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 361
Reduced Incretin Effect in Type 2 Diabetes
Knop, F. K., Vilsbøll, T., Højberg, P. V., Larsen, S., Madsbad, S., Vølund, A., Holst, J. J., & Krarup, T. (2007) · Diabetes · doi:10.2337/db07-0100 · Cited by 349
the DECODA Study Group, & Nakagami, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1334-6 · Cited by 333
Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes
Fukushima, M., Suzuki, H., & Seino, Y. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.024 · Cited by 313
Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes
Pi-Sunyer, F. X., Schweizer, A., Mills, D., & Dejager, S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.009 · Cited by 312
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
Vilsbøll, T., Rosenstock, J., Yki‐Järvinen, H., Cefalu, W. T., Chen, Y., Luo, E., Musser, B., Andryuk, P. J., Ling, Y., Kaufman, K. D., et al. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01173.x · Cited by 305
Lithell, H., & Zethelius, B. (1998) · Cited by 304
Larger Amounts of Visceral Adipose Tissue in Asian Americans
Park, Y., Allison, D. B., Heymsfield, S. B., & Gallagher, D. (2001) · Obesity Research · doi:10.1038/oby.2001.49 · Cited by 304
Del Prato, S., Barnett, A. H., Huisman, H., Neubacher, D., Woerle, H. ‐., & Dugi, K. A. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01350.x · Cited by 299
Jadzinsky, M., Pfützner, A., Paz‐Pacheco, E., Xu, Z., Allen, E., Chen, R., & CV181‐039 Investigators (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01056.x · Cited by 296
Taskinen, M. ‐., Rosenstock, J., Tamminen, I., Kubiak, R., Patel, S., Dugi, K. A., & Woerle, H. ‐. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01326.x · Cited by 294
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
Rosenstock, J., Aguilar-Salinas, C., Klein, E., Nepal, S., List, J., Chen, R., & for the CV181-011 Study Investigators (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903178735 · Cited by 288
Garber, A. J., Schweizer, A., Baron, M. A., Rochotte, E., & Dejager, S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00684.x · Cited by 268
Scott, R., Wu, M., Sanchez, M., & Stein, P. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01246.x · Cited by 260
Raz, I., Chen, Y., Wu, M., Hussain, S., Kaufman, K. D., Amatruda, J. M., Langdon, R. B., Stein, P. P., & Alba, M. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x260925 · Cited by 260
Rosenstock, J., Kim, S. W., Baron, M. A., Camisasca, R. ‐., Cressier, F., Couturier, A., & Dejager, S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00698.x · Cited by 255 · cited 1×
“gov [18, 19, 21–61].”
Ristic, S., Byiers, S., Foley, J., & Holmes, D. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00539.x · Cited by 248
Rosenstock, J., Sankoh, S., & List, J. F. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00876.x · Cited by 234
Garber, A. J., Foley, J. E., Banerji, M. A., Ebeling, P., Gudbjörnsdottir, S., Camisasca, R. ‐., Couturier, A., & Baron, M. A. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00859.x · Cited by 230
DeFronzo, R. A., Fleck, P. R., Wilson, C. A., Mekki, Q., & on behalf of the Alogliptin Study 010 Group (2008) · Diabetes Care · doi:10.2337/dc08-1035 · Cited by 227
Scott, R., Loeys, T., Davies, M. J., Engel, S. S., & for the Sitagliptin Study 801 Group (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00839.x · Cited by 223
Impaired regulation of the incretin effect in patients with type 2 diabetes
Bagger, J. I., Knop, F. K., Lund, A., Vestergaard, H., Holst, J. J., & Vilsbøll, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2435 · Cited by 219
Owens, D. R., Swallow, R., Dugi, K. A., & Woerle, H. J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03387.x · Cited by 214
Matsumoto, K., Miyake, S., Yano, M., Ueki, Y., Yamaguchi, Y., Akazawa, S., & Tominaga, Y. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1562 · Cited by 212
Dejager, S., Razac, S., Foley, J., & Schweizer, A. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-970422 · Cited by 211
Hollander, P., Li, J., Allen, E., Chen, R., & for the CV181-013 Investigators (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0550 · Cited by 208
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
Nonaka, K., Kakikawa, T., Sato, A., Okuyama, K., Fujimoto, G., Kato, N., Suzuki, H., Hirayama, Y., Ahmed, T., Davies, M. J., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.021 · Cited by 208
Nauck, M. A., Ellis, G. C., Fleck, P. R., Wilson, C. A., Mekki, Q., & for the Alogliptin Study 008 Group (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01933.x · Cited by 205
Pratley, R., Jauffret-Kamel, S., Galbreath, E., & Holmes, D. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-944546 · Cited by 194
Rosenstock, J., Rendell, M. S., Gross, J. L., Fleck, P. R., Wilson, C. A., & Mekki, Q. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01124.x · Cited by 189
Qiao, Q., Jousilahti, P., Eriksson, J., & Tuomilehto, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2910 · Cited by 189
Gomis, R., Espadero, R. ‐., Jones, R., Woerle, H. J., & Dugi, K. A. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01391.x · Cited by 177
Bosi, E., Dotta, F., Jia, Y., & Goodman, M. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01040.x · Cited by 173
Pratley, R. E., Kipnes, M. S., Fleck, P. R., Wilson, C., Mekki, Q., & Alogliptin Study 007 Group (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01016.x · Cited by 162
Mohan, V., Yang, W., Son, H.-Y., Xu, L., Noble, L., Langdon, R. B., Amatruda, J. M., Stein, P. P., & Kaufman, K. D. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.009 · Cited by 161
Hanefeld, M., Herman, G. A., Wu, M., Mickel, C., Sanchez, M., Stein, P. P., & on behalf of the Sitagliptin Study 014 investigators (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188152 · Cited by 160
Pratley, R. E., Reusch, J. E. B., Fleck, P. R., Wilson, C., Mekki, Q. A., & on behalf of the Alogliptin Study 009 Group (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903156111 · Cited by 138
Forst, T. M., Uhlig‐Laske, B., Ring, A., Graefe‐Mody, U., Friedrich, C., Herbach, K., Woerle, H. J., & Dugi, K. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03131.x · Cited by 133
Iwamoto, Y., Taniguchi, T., Nonaka, K., Okamoto, T., Okuyama, K., Ferreira, J. C. A., & Amatruda, J. M. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-272 · Cited by 115
Rosenstock, J., Inzucchi, S. E., Seufert, J., Fleck, P. R., Wilson, C., & Mekki, Q. A. (2010) · Diabetes Care · doi:10.2337/dc10-0159 · Cited by 112
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 110
Self-citationYang, W., Pan, C. Y., Tou, C., Zhao, J., & Gause‐Nilsson, I. A. M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.07.035 · Cited by 103
Reasner, C. A., Olansky, L., Seck, T. L., Williams‐Herman, D., Chen, M., Terranella, L., Johnson‐Levonas, A. O., Kaufman, K. D., & Goldstein, B. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01390.x · Cited by 95
Kikuchi, M., Abe, N., Kato, M., Terao, S., Mimori, N., & Tachibana, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.006 · Cited by 94
Kaku, K., Itayasu, T., Hiroi, S., Hirayama, M., & Seino, Y. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01460.x · Cited by 88
Aso, Y., Ozeki, N., Terasawa, T., Naruse, R., Hara, K., Suetsugu, M., Takebayashi, K., Shibazaki, M., Haruki, K., Morita, K., et al. (2011) · Translational research · doi:10.1016/j.trsl.2011.09.005 · Cited by 83
Seino, Y., Fujita, T., Hiroi, S., Hirayama, M., & Kaku, K. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.599371 · Cited by 79
Goodman, M., Thurston, H. J., & Penman, J. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1104604 · Cited by 75
Pharmacokinetics and Pharmacodynamics of Vildagliptin in Healthy Chinese Volunteers
Hu, P., Yin, Q., Deckert, F., Jiang, J., Liu, D., Kjems, L., Dole, W. P., & He, Y. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008325152 · Cited by 63
Seino, Y., Fujita, T., Hiroi, S., Hirayama, M., & Kaku, K. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.614936 · Cited by 60
Kikuchi, M., Haneda, M., Koya, D., Tobe, K., Onishi, Y., Couturier, A., Mimori, N., Inaba, Y., & Goodman, M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.017 · Cited by 56
Yoon, K., Shockey, G., Teng, R., Golm, G. T., Thakkar, P., Meehan, A. G., Williams‐Herman, D., Kaufman, K. D., Amatruda, J. M., & Steinberg, H. O. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02589.x · Cited by 53
(2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00735.x · Cited by 53
Rhee, E., Lee, W., Yoon, K., Yoo, S. J., Lee, I. K., Baik, S. H., Kim, Y. K., Lee, M. ‐., Park, K. S., Park, J. Y., et al. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01303.x · Cited by 41
Self-citationKashiwagi, A., Kadowaki, T., Tajima, N., Nonaka, K., Taniguchi, T., Nishii, M., Ferreira, J. C. A., & Amatruda, J. M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00120.x · Cited by 27
Chien, M.-N., Lee, C., Chen, W.-C., Liu, S.-C., Leung, C.-H., & Wang, C. (2011) · International journal of gerontology · doi:10.1016/j.ijge.2011.04.015 · Cited by 22
Decreased Insulin Secretion but Not Insulin Sensitivity in Normal Glucose Tolerant Thai Subjects
Rattarasarn, C., Soonthornpan, S., Leelawattana, R., & Setasuban, W. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-2250 · Cited by 17
Cited by
Diabetic kidney disease: a report from an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Epidemiology of diabetes and diabetic complications in China
Ma, R. C. W. (2018) · Diabetologia · doi:10.1007/s00125-018-4557-7 · Cited by 491
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0022 · Cited by 400
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
Deacon, C. F. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0399-8 · Cited by 398
Metadata
- Authors
- Kim, Y. G., Hahn, S., Oh, T. J., Kwak, S. H., Park, K. S., & Cho, Y. M.
- Venue
- Diabetologia
- Published
- 2013-01-24
- Volume
- 56
- Issue
- 4
- Pages
- 696-708
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1998401806
- Cited by
- 396
- References
- 84
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.